Therapeutic targets and new directions for antibodies developed for ovarian cancer

Antibody therapeutics against different target antigens are widely used in the treatment of different malignancies including ovarian carcinomas, but this disease still requires more effective agents. Improved understanding of the biological features, signaling pathways, and immunological escape mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Bax, Heather J., Josephs, Debra H., Pellizzari, Giulia, Spicer, James F., Montes, Ana, Karagiannis, Sophia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098446/
https://www.ncbi.nlm.nih.gov/pubmed/27494775
http://dx.doi.org/10.1080/19420862.2016.1219005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098446/
https://www.ncbi.nlm.nih.gov/pubmed/27494775
http://dx.doi.org/10.1080/19420862.2016.1219005

Ejemplares similares